Agios Pharmaceuticals Inc... (AGIO)
NASDAQ: AGIO
· Real-Time Price · USD
37.00
0.32 (0.87%)
At close: Aug 15, 2025, 3:59 PM
37.14
0.38%
After-hours: Aug 15, 2025, 07:37 PM EDT
Agios Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 40.88M | 37.03M | 36.5M | 32.87M | 31.31M | 29.4M | 26.82M | 24.03M | 20.15M | 19.02M | 14.24M | 9.93M | 6.41M | 38.18M | 78.76M | 122.8M | 157.51M | 157.51M |
Cost of Revenue | 6.09M | 6.22M | 7.11M | 7.83M | 7.68M | 5.71M | 4.28M | 2.71M | 2.59M | 1.92M | 1.7M | 5.9M | 9.96M | 10.2M | 10.57M | 6.92M | 2.98M | 2.98M |
Gross Profit | 34.79M | 30.82M | 29.39M | 25.04M | 23.62M | 23.7M | 22.54M | 21.32M | 17.55M | 17.1M | 12.54M | 4.03M | -3.55M | 27.98M | 68.19M | 115.88M | 154.53M | 154.53M |
Operating Income | -461.53M | -440.29M | -425.74M | -406.98M | -405.06M | -392.95M | -391.49M | -384.38M | -374.57M | -378.51M | -389.05M | -394.7M | -394.76M | -388.35M | -378.42M | -366.02M | -365.2M | -364.17M |
Interest Income | 45.59M | 39.19M | 48.08M | 38.69M | 34.01M | 34.14M | 33.34M | 31.21M | 26.65M | 20.19M | 12.79M | 6.64M | 3.08M | 1.28M | 928K | 1.39M | 2.25M | 4.01M |
Pretax Income | 694.33M | 710.23M | 717.97M | 727.43M | -364.93M | -352.62M | -352.09M | -219.62M | -210.04M | -218.04M | -231.8M | -366.91M | -369.42M | -360.41M | -356.51M | -355.58M | -370.3M | -377.99M |
Net Income | 650.08M | 665.99M | 673.73M | 674.31M | -364.93M | -352.62M | -342.49M | -74.33M | -55.41M | -63.41M | -80.39M | -347.24M | -363.6M | -358.01M | 1.6B | 1.6B | 1.59B | 1.59B |
Selling & General & Admin | 177.63M | 167.3M | 156.78M | 140.39M | 127.68M | 122.55M | 119.9M | 117.37M | 120.67M | 118.53M | 121.67M | 120.43M | 118.46M | 119.41M | 121.44M | 129.69M | 137.38M | 144.12M |
Research & Development | 318.69M | 303.82M | 298.35M | 291.62M | 301.01M | 294.09M | 294.12M | 288.33M | 271.46M | 277.09M | 279.91M | 282.91M | 281.94M | 269.43M | 256.97M | 279.42M | 304.97M | 333.88M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.27M | 7.91M | 7.91M | 7.91M | 4.64M | n/a | n/a |
Operating Expenses | 496.32M | 471.11M | 455.13M | 432.01M | 428.68M | 416.64M | 414.03M | 405.7M | 392.13M | 395.61M | 401.58M | 403.34M | 400.4M | 388.84M | 378.42M | 409.11M | 442.35M | 478M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.01M | 15.78M | 17.83M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 502.41M | 477.33M | 462.24M | 439.85M | 436.37M | 422.35M | 418.31M | 408.41M | 394.72M | 397.53M | 403.29M | 404.63M | 401.18M | 389.18M | 378.42M | 410.07M | 443.95M | 480.27M |
Income Tax Expense | 44.24M | 44.24M | 44.24M | 53.12M | n/a | n/a | -9.6M | -145.29M | -154.64M | -154.64M | -151.41M | -15.38M | -6.04M | -4.52M | 1.85M | 1.52M | 2.63M | 2.88M |
Shares Outstanding (Basic) | 57.93M | 57.46M | 57.16M | 56.94M | 56.8M | 56.38M | 55.9M | 55.8M | 55.5M | 55.11M | 54.79M | 54.84M | 54.8M | 54.47M | 54.34M | 57.05M | 61.07M | 69.54M |
Shares Outstanding (Diluted) | 57.93M | 57.46M | 57.16M | 58.43M | 56.8M | 56.38M | 55.9M | 55.8M | 55.6M | 55.27M | 54.79M | 54.84M | 54.8M | 54.56M | 54.34M | 57.05M | 61.07M | 69.54M |
EPS (Basic) | 11.47 | 11.71 | 11.81 | 11.79 | -6.5 | -6.32 | -6.17 | -1.31 | -0.99 | -1.16 | -1.48 | -6.36 | -6.6 | -6.33 | 22.24 | 22.57 | 22.70 | 22.80 |
EPS (Diluted) | 11.07 | 11.31 | 11.41 | 11.36 | -6.5 | -6.32 | -6.16 | -1.3 | -0.98 | -1.15 | -1.48 | -6.36 | -6.6 | -6.33 | 22.24 | 22.57 | 22.70 | 22.80 |
EBITDA | -442.59M | -436.06M | -421.43M | -402.63M | -399.1M | -386.76M | -384.86M | -377.35M | -367.18M | -370.64M | -380.48M | -385.75M | -385.58M | -379.11M | -369.18M | -353.23M | -351.1M | -348.22M |
EBIT | -446.5M | -440.29M | -425.74M | -406.98M | -405.06M | -392.95M | -391.49M | -384.38M | -374.57M | -378.51M | -389.05M | -394.7M | -394.76M | -388.35M | -378.42M | -365.23M | -363.29M | -360.5M |
Depreciation & Amortization | 5.25M | 5.58M | 5.65M | 5.69M | 5.97M | 8.84M | 11.89M | 14.86M | 17.73M | 18.04M | 18.56M | 18.79M | 18.88M | 18.8M | 18.78M | 16.84M | 14.58M | 12.3M |